Craneware starts year well, investors told

Investors in healthcare software and supporting services supplier Craneware were told on Wednesday that the company has experienced a “positive start” to trading in the first four months of the year, as they gathered for the annual general meeting.

The AIM-traded firm’s chairman, Keith Neilson, said that positive start added to its recently-announced $6m contract win to extend the scope of solutions provided to an existing unnamed customer.

“In June, we launched Trisus Claims Informatics, the first product on our cloud-based Trisus platform, to which we have seen a positive market response,” Neilson noted.

“In addition, we are seeing very encouraging results for the early adopters of our Trisus Cost Analytics Resource Efficiency product, which is currently under development within Craneware Healthcare Intelligence.”

Neilson added that the company’s sales activity and the early product successes demonstrated how it was benefiting from ongoing investments in its ‘value cycle’ product suite, ensuring it had the solutions to provide insight into key areas of hospital operations, expanding its market opportunity and increasing its strategic value within the market.

“Our leadership in this area has further strengthened Craneware's position as a trusted partner for US healthcare organisations as they look to solve the challenges of the new value based reimbursement models.

“This positive impact of the value cycle on current sales and underlying pipelines combined with the high levels of revenue visibility and significant cash reserves, means we are well positioned to continue to execute on our growth strategy.”